Tag: Top selling drugs

In 2024, Keytruda (pembrolizumab) dominated global sales, reaching nearly $29.5 billion, showcasing the immense value of specialized, high-cost therapies in the market. But pinpointing exactly what drug sells the most in the USA is not a simple question, as the answer varies significantly depending on whether the measure is total revenue or the sheer number of prescriptions dispensed.

According to data from 2024, Merck's cancer drug Keytruda has claimed the top spot in global pharmaceutical sales, showcasing a significant shift in the market after years of AbbVie's Humira leading the pack. For those asking, 'What is the top selling drug in America?', the answer has become more complex, reflecting major changes driven by biosimilar competition, new drug classes, and shifting patient needs.

In 2023, global pharmaceutical sales reached $60.12 billion for just one company, Merck [1.4.2]. Within this massive industry, what is the most sold drug? The answer depends on whether it's measured by global revenue or the number of prescriptions filled.